Imre Bata

Budapest, BU 1475, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Development of dual V1a/V2 antagonists containing triazolobenzazepine scaffold.

Development of dual V1a/V2 antagonists containing triazolobenzazepine scaffold.

Journal: European journal of medicinal chemistry

Published: October 02, 2024

Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist.

Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist.

Journal: Journal of medicinal chemistry

Published: January 02, 2024

Novel-Type GABAB PAMs: Structure-Activity Relationship in Light of the Protein Structure.

Novel-Type GABAB PAMs: Structure-Activity Relationship in Light of the Protein Structure.

Journal: ACS medicinal chemistry letters

Published: December 20, 2023

Optimization of Novel α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulators and the Discovery of a Preclinical Development Candidate Molecule (RGH-560).

Optimization of Novel α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulators and the Discovery of a Preclinical Development Candidate Molecule (RGH-560).

Journal: Journal of medicinal chemistry

Published: November 21, 2023

Identification of Triazolopyridines as Selective α5-GABAA Receptor Negative Allosteric Modulators by a Hybridization Approach.

Identification of Triazolopyridines as Selective α5-GABAA Receptor Negative Allosteric Modulators by a Hybridization Approach.

Journal: ACS chemical neuroscience

Published: December 16, 2022

Novel imidazo[1,5-a]quinoxaline derivatives: SAR, selectivity and modeling challenges en route to the identification of an α5-GABAA receptor NAM.

Novel imidazo[1,5-a]quinoxaline derivatives: SAR, selectivity and modeling challenges en route to the identification of an α5-GABAA receptor NAM.

Journal: Bioorganic & medicinal chemistry letters

Published: August 30, 2022

Multiparameter Optimization of Naphthyridine Derivatives as Selective α5-GABAA Receptor Negative Allosteric Modulators.

Multiparameter Optimization of Naphthyridine Derivatives as Selective α5-GABAA Receptor Negative Allosteric Modulators.

Journal: Journal of medicinal chemistry

Published: May 18, 2022

Synthesis and Characterization of New V1A Antagonist Compounds: The Separation of Four Atropisomeric Stereoisomers.

Synthesis and Characterization of New V1A Antagonist Compounds: The Separation of Four Atropisomeric Stereoisomers.

Journal: Journal of medicinal chemistry

Published: July 13, 2021

Discovery of New Heterocyclic Ring Systems as Novel and Potent V1A Receptor Antagonists.

Discovery of New Heterocyclic Ring Systems as Novel and Potent V1A Receptor Antagonists.

Journal: ACS chemical neuroscience

Published: October 21, 2020

New V1a receptor antagonist. Part 1. Synthesis and SAR development of urea derivatives.

New V1a receptor antagonist. Part 1. Synthesis and SAR development of urea derivatives.

Journal: Bioorganic & medicinal chemistry letters

Published: July 01, 2020

New V1a receptor antagonist. Part 2. Identification and optimization of triazolobenzazepines.

New V1a receptor antagonist. Part 2. Identification and optimization of triazolobenzazepines.

Journal: Bioorganic & medicinal chemistry letters

Published: July 01, 2020

II. Discovery of a novel series of CXCR3 antagonists with a beta amino acid core.

II. Discovery of a novel series of CXCR3 antagonists with a beta amino acid core.

Journal: Bioorganic & medicinal chemistry letters

Published: August 19, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026